- *Corresponding Author:
- C. Y. Han
College of Animal Science and Technology, Anhui Agricultural University, 130 West Changjiang Road, Shushan District, Anhui 230036, P. R. China
|Date of Submission||30 May 2017|
|Date of Revision||03 February 2018|
|Date of Acceptance||06 August 2018|
|Indian J Pharm Sci 2018;80(5):852-857|
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms
Osthole extracted from Cnidii Fructus, a herb used in traditional Chinese medicine, was reported to possess multiple activities such as antibacterial, antiinflammatory, antitumor and insecticidal. However, its antifungal activity against Microsproum canis has not been investigated yet. The present study aimed to investigate the antifungal effect of osthole against Microsproum canis. The minimum inhibitory concentration and a growth inhibitory curve of osthole on Microsporum canis were according to the program of M38-A2 of Clinical and Laboratory Standards Institute. HPLC analysis, aniline blue test and spectrophotometry were used to determine contents of ergosterol, 1,3-β-D-glucan and chitin from Microsporum canis, respectively. The results indicated that minimum inhibitory concentration of osthole against Microsporum canis was 1.95 µg/ml. HPLC analysis demonstrated that there was no significant change in the content of ergosterol between the osthole and control group. Compared with the control group, the content of 1,3-β-D-glucan and chitin in the cell wall of Microsporum canis was decreased. Taken together, this research showed that osthole could notably inhibit the growth of Microsporum canis and the antifungal activity was related to inhibiting the biosynthesis of 1,3-β-D-glucan and chitin in the cell wall of Microsporum canis, making osthole a potential future antifungal agent.
Osthole, Microsporum canis, ergosterol, cell wall, 1,3-β-D-glucan, chitin
Microsporum canis is one of the common and epidemic pathogenic fungi worldwide that can invade keratinized structures and infect hair, skin and nails of humans and animals. Furthermore, M. canis is zoonotic in nature and highly contagious to Feline, Canis and Homo sapiens [1,2]. The animals could be infected by M. canis during each season, notably, it has the highest incidence rate in the hot and damp seasons . The pathogen causing 60 % of fungal skin diseases of canis and 98 % dermatophytes diseases of feline was found to be M. canis . Once the animals infected by M. canis, the disease is hard to cure since it relapses easily and may generate cross-infection with other pathogens, which is characterized by increasing furfur, forming scab, exuding body fluid, pruritus and so on [5,6].
Osthole, 7-methoxy-8-(3-methyl-2-butenyl) coumarin (Figure 1), is a coumarin derivative extracted from Cnidii Fructus, a traditional Chinese medical herb . Previous studies have showed that osthole could exert antibacterial, antiinflammatory, antitumor and insecticidal activities, relieve heart disorder, dilate blood vessels and lower blood pressure [8-12]. A recent report showed that osthole could prevent the reproduction of Alternaria and Cryptococcus neoformans . However, there is no investigation focusing on the antifungal activity and the possible targets of antifungal properties of osthole. Therefore, this preliminary assessment to investigate the inhibitory effect of osthole on M. canis was taken up.
Materials and Methods
Osthole (>98 % HPLC purity) was purchased from Nanning Innovative Pharmaceutical Technology Co., Ltd. (Guangxi, China). Caspofungin was obtained from New Pioneer Pharmaceutical Company (Shanghai, China). Terbinafine was purchased from Dalian Meilun Bio-Technology Co., Ltd. (Dalian, China). Ergosterol, aniline blue and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich Chemicals (St. Louis, MO, USA). Sabouraud dextrose agar (SDA) was purchased from Qingdao Hope BioTechnology (Shandong, China). RPMI-1640 liquid medium was purchased from Yuan Ye BioTechnology Co., Ltd. (Shanghai, China). Other reagents were obtained from Sinopharm Chemical Reagent Co. Ltd., Shanghai Shi, China.
Microsporum canis (YUMCC Ym3099) was provided by the laboratory of fungi of Department of Clinical Veterinary Medicine at China Agricultural University in Beijing, China. M. canis was grown on SDA and incubated at 28° for 7 d, then picked single colony and cultured in Sabouraud dextrose broth. The concentration of M. canis was adjusted to 5×105 colony forming units (CFU)/ml using RPMI-1640 medium, and this suspension was used as inocula for the following inhibition assays.
Determination of minimum inhibitory concentration (MIC)
The MIC was determined with broth microdilution methods based on the reference document M38-A2 for yeast and filamentous fungi formulated by the Clinical and Laboratory Standard Institute (CLSI) . Osthole, terbinafine and caspofungin were dissolved in DMSO and further diluted to final concentrations with RPMI- 1640 medium. The final concentrations of osthole, terbinafine and caspofungin were 15.6, 0.8 and 0.16 μg/ml, respectively. The final DMSO concentration was ≤0.1 % (v/v). One hundred microliters of RPMI- 1640 broth was added into each well of 96-well microtiter plates (Corning, NY, USA). Then either 100 μl osthole solution, terbinafine solution or caspofungin solution were added to the first well, and the multiple proportion dilution was conducted to obtain different final drug concentrations. The above wells were supplemented with 100 μl spore suspension (5×105 CFU/ ml) and for controls additional wells were only added to 200 μl RPMI-1640 medium, respectively. The plates were incubated for 7 d at 28° and performed in triplicate at each concentration. The absorbance at 620 nm was measured with a microplate reader (Bio-Rad, Foster, California, USA).
Inhibition curves of osthole, terbinafine and caspofungin on M. canis
M. canis (5×105 CFU/ml) was treated with osthole, terbinafine and caspofungin at MIC concentrations during the logarithmic phase of its growth. After shaking for 0, 1, 2, 4, 8, 12, 24, 36, 48 and 72 h at 28°, the inhibitory effect of the compounds on M. canis was measured with the aid of a haemocytometer and growth inhibition curves were plotted.
High-performance liquid chromatography (HPLC) analysis
M. canis was treated during logarithmic phase of its growth with osthole, terbinafine and caspofungin at MIC concentration for 24 h, respectively. After 7 d of incubation, M. canis hyphae was harvested by centrifugation at 1300 rpm for 15 min and washed twice with phosphate buffered saline at room temperature. The hyphae was collected, and resuspended in 15 ml saponifier and then incubated at 80° for 90 min. Then, 15 ml petroleum ether was added and incubated for 60 min. After being dried, the non-saponifiable extract was collected dissolved with methanol, and filtered with a Millipore filter of 0.22 μm. The aliquot was used for HPLC detection .
The condition of chromatographic detection was 284 nm at 1 ml/min flow rate with 100 % methanol as mobile phase and column temperature at 35° . Standard solution with different concentrations of ergosterol was prepared, and the sample was determined under the above chromatographic conditions. The standard curve of ergosterol was drawn by setting the concentration as abscissa and the peak area as the vertical. The resultant precision, stability and recovery of the HPLC methods were evaluated.
Measurement of 1,3-β-D-glucan
The content of 1,3-β-D-glucan was determined using aniline blue assay . Briefly, 50 μl suspensions of M. canis was added into 10 ml RPMI-1640 medium containing osthole or caspofungin at MIC concentration, respectively. After incubation at 28° for 7 d, the M. canis was collected by centrifugation at 1300 rpm for 3 min, then washed twice with 0.1 M NaOH solution and freeze-dried for 16 h. A total of 5 mg M. canis was added into 250 μl 1 M NaOH solution. The mixture was blended for 30 s and incubated for 30 min at 52°. A volume of 50 μl the above mixture and 185 μl aniline blue (0.067 % aniline blue, 0.35 M HCl, 0.98 M glycine-NaOH, pH 9.5) were added into 96-well plates with triplicate and then incubated for 30 min at 52°. Absorbance was measured in a microplate reader (Bio-Rad, Foster, California, USA) at excitation/emission 410/458 nm.
Measurement of chitin
The content of chitin was determined as previously described . A volume of 50 μl suspensions of M. canis was added into 10 ml RPMI-1640 medium containing osthole or caspofungin at MIC concentration, respectively. After incubation at 28° for 7 d, the M. canis was collected by centrifugation at 1300 rpm for 3 min, then washed twice with 0.1 M NaOH solution and freeze-dried for 16 h. Briefly, 5 mg M. canis was resuspended in 3 ml KOH saturated solution, incubated for 1 h at 130°, added 8 ml 75 % ice-cold ethanol for 15 min in ice bath, and then mixed with a volume of 300 μl diatomite 545 suspension (13.3 %), and centrifuged at 2000 rpm for 5 min at 2°. The precipitate was washed once with 10 ml ice-cold ethanol (40 %), and then washed twice with 10 ml ice-cold water. The precipitate was resuspended in 500 μl sterile distilled water, 500 μl NaNO2 (5 %) and 500 μl KHSO4 (5 %), and then centrifuged at 2000 rpm for 2 min at 2°. After centrifugation, 150 μl supernatant was transferred to sterile tubes and then 450 μl sterile distilled water, 200 μl aqueous ammonia (12.5 %) and 200 μl 5 mg/ml 3-methylbenzothiazolinone-2-hydrazone were added and incubated for 3 min at 130°. The mixture was procedurally cooled down to room temperature, and 200 μl 0.83 % FeCl3 was added, followed by incubation for 25 min at room temperature. Every sample was detected at 650 nm using spectrophotometer.
Results from a representative of three independent experiments were expressed as means±standard deviation (SD), and analysed using the one-way analysis of variance (ANOVA) followed by least significant difference test for multiple comparisons, and post-hoc test using SPSS 21.0 (SPSS, Inc., Chicago, IL, USA).
Results and Discussion
At present, synthetic drugs, including triazoles, polyenes and others, are being widely used for treating M. canis infection. With the wide application of these drugs as antifungal agents multidrug resistant fungi emerged on the clinical front . Besides, the synthetic drugs also possessed certain deficiencies such as a poor curative effect on antifungal therapy . Sensitivity to triazoles became reduced due to the deficiency of AmB binding sites, which could inhibit ergosterol biosynthesis . Polyenes could inhibit the growth of fungi by interacting with ergosterol in cell membrane, but are ineffective on fungus without ergosterol in cell membrane . Although the drugs designed for the cell wall of fungi such as caspofungin, micafungin and anidulafungin, have acquired corresponding progress, the drug species has been limited . Therefore, in recent years natural product and active ingredient contained from those have attracted more and more attention, which could provide a new choice for the treatment of fungal diseases.
In this study, the results indicated that that MIC of osthole, terbinafine and caspofungin against M. canis were 1.95, 0.10 and 0.02 μg/ml, respectively. The number of viable fungi was not changed after treated with MIC of osthole, terbinafine and caspofungin for 1, 2, 4, 8, and 12 h. After being stimulated with osthole for 24 h, the number of viable fungi was significantly inhibited, and the effect of viable M. canis inhibition induced by osthole for 36 h was more serious. An obvious decrease in the number of viable fungi occurred after treatment with terbinafine and caspofungin for 24 h (Figure 2). The number of viable fungi significantly decreased with passage of time of exposure to osthole, terbinafine and caspofungin and declined to zero rapidly in the three groups, which suggested that osthole could absolutely inhibit the growth of M. canis within 36 h and exert the antifungal effect on M. canis. The results indicated that 1.95 μg/ml osthole and 0.02 μg/ml caspofungin could inhibit the growth of M. canis absolutely within 36 h, while the time of terbinafine inhibit the growth of M. canis absolutely was significantly greater than that of osthole. It was suggested that osthole has a good prospect in the treatment of infectious disease of M. canis.
Figure 2: Inhibitory curves of osthole, terbinafine and caspofungin
on Microsporum canis
The logarithmic phase of M. canis (5×105 CFU/ml) was exposed to MIC concentrations of osthole, terbinafine and caspofungin for 0, 1, 2, 4, 8, 12, 24, 36, 48 and 72 h, respectively. Data represent means±SD of 3 independent determinations and differences between mean values were assessed by oneway ANOVA. Control group; osthol group; terbinafine group; caspofungin group
Ergosterol, the main steroidal substance in the fungal cell membrane, can maintain integrity, viability and normal growth of fungi. In addition, ergosterol can adjust cell membrane fluidity by combining with phospholipid [17,19]. The fungal cell might suffer fracture due to the lack of ergosterol . Some agents exhibited antifungal activity by inhibiting biosynthesis of ergosterol or interacting with ergosterol, and destroying the cell membrane structure of fungi [17,20]. Terbinafine, a polyene antifungal drug, was set as a standard inhibitor of ergosterol synthesis. The content of ergosterol was detected by HPLC after the interaction of osthole with M. canis. The standard curve equation of ergosterol obtained was y=1.7389x–2.5539 (r=0.999) under the liquid chromatograph condition. HPLC analysis results demonstrated that the content of ergosterol in osthole group and control group was significantly higher than that in terbinafine group, while no significant change was found in ergosterol content between osthole group and control group (Figures 3 and 4). The results demonstrated that osthole did not inhibit ergosterol biosynthesis in the cell membrane, which suggested that the antifungal activity of osthole could be related to the synthesis of cell wall.
Figure 3: Effect of osthole on ergosterol in Microsporum canis
Effect of osthole on ergosterol content of M. canis was measured using HPLC assay. The logarithmic phase of M. canis (5×105 CFU/ml) was treated with MIC concentration of osthole and terbinafine for 24 h, respectively. Data represent means±SD of three separate experiments and differences between mean values were assessed by one-way ANOVA. **P<0.01 indicates the significant difference compared with control group
The fungi is endowed with a cell wall to maintain its cell shape and transmit the signals. The loss of cell wall structure or function can lead to the loss of cellular homeostasis, which ultimately leads to cell death. It was reported that the destruction of fungal cell wall might cause dissolution of fungal cells, which eventually cause fungal death [17,21]. Therefore, the fungal cell wall is the ideal targets of antifungal agents . The main components of the fungal cell walls are 1,3-β-D-glucan and chitin, which do not exist in mammalian cells. Some studies have shown that the transcription levels and activities of chitinase and chitin synthase were significantly increased during the transformation of yeast to hyphal form of Candida albicans [23,24]. After cloning the chitinase gene and then performing site directed mutagenesis, the chitinase has obvious effect on both morphology and growth rate of mycelial and spore [25,26]. Moreover, chitinase plays an important physiological role in the building process of fungal cell wall, and its major function is to assist in synthesis of chitin synthase, and process and modify for synthesized chitin to achieve perfect space configuration of cell wall [27,28]. Thus, deficiency or insufficiency of chitinase will affect the normal growth of mycelium, and then influence the virulence of pathogenic fungi. 1,3-β-D-glucan has effect on maintaining the normal shape of the fungal cell, when the fungal invade the deep part of body, and then it is processed by macrophage, the lots of 1,3-β-Dglucan will be released; thus, 1,3-β-D-glucan could be considered as a target molecule of fungal infection in clinical examination . Besides, it is also reported that 1,3-β-D-glucan, a fungal surface antigen, can cause a variety of immune responses in animal body [28,29]. In the past several decades, there appeared antifungal agent which can destroy cell walls by inhibiting the biosynthesis of chitin and 1,3-β-D-glucan, such as echinocandins and caspofungins . To investigate the effects of osthole on fungal cell wall synthesis, we carried out specific test to detect the content of fungal 1,3-β-D glucan and chitin. The content of 1,3-β-Dglucan in both osthole group and caspofungin group was significantly lower than that in control group, while no significant change was found in the 1,3-β-Dglucan content between osthole group and caspofungin group (Figure 5A). The data demonstrated that the content of chitin in both osthole group and caspofungin group was significantly decreased compared with the control group, while there was no significant difference in the content of chitin between osthole group and caspofungin group (Figure 5B). The results of this study indicated that the osthole has apparent inhibitory effect both on chitin and 1,3-β-D-glucan biosynthesis. Thus, osthole has stronger inhibition on inherent components of the M. canis cell wall.
In summary, our investigation demonstrated that osthole exerted an antifungal effect on M. canis by decreasing the content of 1,3-β-D glucan and chitin, thereby interfering with the biosynthesis of fungal cell wall, and these results make a strong case that osthole could be a potential antifungal in place of the existing drugs.
This work was financially supported by the National Natural Science Foundation of China (Grant No. 31772786) and the Open Project Program of Beijing Key Laboratory of Traditional Chinese Veterinary Medicine at Beijing University of Agriculture (TCVM 201701). We extremely thank Jingang Gu associate researcher for his kind help, and we also thank the Key Laboratory of Microbial Resource Collection and Preservation for providing the conditions for the investigation.
Conflict of interest
The author declares that there is no conflict of interest regarding the publication of this paper.
- Mancianti F, Nardoni S, Corazza M, D’Achille P, Ponticelli C. Environmental detection of Microsporum canis arthrospores in the households of infected cats and dogs. J Feline Med Surg 2003;5:323-8.
- Hermoso de Mendoza M, Hermoso de Mendoza J, Alonso JM, Rey JM, Sanchez S, Martin R, et al.A zoonotic ringworm outbreak caused by a dysgonic strain of Microsporum canis from stray cats . Rev Iberoam Micol 2010;27:62-5.
- Yin B, Xiao Y, Ran Y, Kang D, Dai Y, Lama J. Microsporum canis infection in three familial cases with Tinea capitis and Tinea corporis.Mycopathologia 2013;176:259-65.
- Chah KF, Majiagbe KA, Kazeem HM, Ezeanyika O, Agbo IC. Dermatophytes from skin lesions of domestic animals in Nsukka, Enugu State, Nigeria. Vet Dermatol 2012;23:522-e104.
- Pasquetti M, Peano A, Soglia D, Min AR, Pankewitz F, Ohst T, et al. Development and validation of a microsatellite marker-based method for tracing infections by Microsporum canis. J Dermatol Sci 2013;2:123-9.
- Cafarchia C, Figueredo LA, Coccioli C, Camarda A, Otranto D. Enzymatic activity of Microsporum canis and Trichophyton mentagrophytes from breeding rabbits with and without skin lesions. Mycoses 2012;1:45-9.
- Chen Z, Mao X, Liu A, Gao X, Chen X, Ye M, et al. Osthole, a natural coumarin improves cognitive impairments and BBB dysfunction after transient global brain ischemia in C57 BL/6J mice: involvement of Nrf2 pathway. Neurochem Res 2015;40:186-94.
- Yu C, Li P, Qi D, Wang L, Qu HL, Zhang YL, et al. Osthole protects sepsis-induced acute kidney injury via down-regulating NF-κB signal pathway. Oncotarget 2017;8:4796-813.
- Hao Y, Liu Y. Osthole alleviates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2/angiotensin-(1-7) axis and decreasing inflammation responses in rats. Biol Pharm Bull 2016;39:457-65.
- Li Z, Ji H, Song X, Hu J, Han N, Chen N. Osthole attenuates the development of carrageenan-induced lung inflammation in rats. Int Immunopharmacol 2014;20(1):33-6.
- Jiang G, Liu J, Ren B, Tang Y, Qwusu L, Li M, et al. Anti-tumor effects of osthole on ovarian cancer cells in vitro. J Ethnopharmacol 2016;193:368-76.
- Liu M, Liu Y, Hua X, Wu C, Zhou S, Wang B, et al. Synthesis of osthole derivatives with grignard reagents and their larvicidal activities on mosquitoes. Chinese J Chem 2015;33:1353-58.
- Xin XL, Dong PP, Wang G, Xi RG, Liu D, Wu ZM, et al. Biotransformation of osthole by alternaria longipes. J Asian Nat Prod Res 2013;15(7):717-22.
- Fortwendel JR, Juvvadi PR, Pinchai N, Perfect BZ, Alspaugh JA, Perfect JR, et al.Differential effects of inhibiting chitin and 1,3-β-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrob Agents Chemother 2009;53(2):476-82.
- Lopes G, Pinto E, Andrade PB, Valentão P. Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor. PLoS One 2013;8:e72203.
- Sanglard D. Emerging treats in antifungal-resistant fungal pathogens. Front Med 2016;3:11.
- Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH. An sight into the antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 2010;9(9):719-27.
- Sui G, Zhang W, Zhou K, Li Y, Zhang B, Xu D, et al. Trialkylamine derivatives containing a triazole moiety as promising ergosterol biosynthesis inhibitor: design, synthesis, and antifungal activity. Chem Pharm Bull 2017;65(1):82-9.
- Récamier KS, Hernández-Gómez A, González-Damián J, Ortega-Blake I. Effect of membrane structure on the action of polyenes: I. Nystatin action in cholesterol- and ergosterol-containing membranes. J Membr Biol 2010;237(1):31-40.
- Ene IV, Adya AK, Wehmeier S, Brand AC, MacCallum DM, Gow NA, et al. Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell Microbiol 2012;14(9):1319-35.
- Levitz SM, Huang H, Ostroff GR, Specht CA. Exploiting fungal cell wall components in vaccines. Semin Immunopathol 2015;37(2):199-207.
- Liu J, Balasubramanian MK. 1,3-beta-Glucan synthase: a useful target for antifungal drugs. Curr Drug Targets Infect Disord 2001;1:159-69.
- Kelly MT, MacCallum DM, Clancy SD, Odds FC, Brown AJ, Butler G. The Candida albicans CaACE2 gene affects morphogenesis, adherence and virulence. Mol Microbiol 2004;53(3):969-83.
- Selvaggini S, Munro CA, Paschoud S, Sanglard D, Gow NA. Independent regulation of chitin synthase and chitinase activity in Candida albicans and Saccharomyces cerevisiae. Microbiology 2004;150:921-8.
- Ohnuma T, Taira T, Yamagami T, Aso Y, Ishiguro M. Molecular cloning, functional expression, and mutagenesis of cDNA encoding class I chitinase from rye (Secale cereale) seeds. Biosci Biotechnol Biochem 2004;68(2):324-32.
- Tjoelker LW, Gosting L, Frey S, Hunter CL, Trong HL, Steiner B, et al.Structural and functional definition of the human chitinase chitin-binding domain. J Biol Chem 2000;275:514-20.
- Chaudhary PM, Tupe SG, Deshpande MV. Chitin synthase inhibitors as antifungal agents.Mini Rev Med Chem 2013;13(2):222-36.
- Verwer PE, ten Kate MT, Falcone FH, Morroll S, Verbrugh HA, Bakker-Woudenberg IA, et al. Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised rats. PLoS One 2013;8(10):e75848.
- Sanglard D, Coste A, Ferrari S. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 2009;9(7):1029-50.